News


Construction of a brand-new company site

Since its foundation in 1993, bitop’s office and production area is located in Witten, Germany. Now, together with its partner Johann Freundlieb GmbH & Co. KG, bitop constructs a brand-new office building and production facility located at the “PHOENIX West” area - an innovative technology and service location in Dortmund. With a 2000 m² production hall and 1550 m² office and laboratory space, bitop will be able to significantly expand its production capacity for Ectoin® and other extremolytes. The symbolic “turn of the sod” already took place in December 2016 and the construction works are currently going on full speed. bitop plans to move in its new facilities in spring 2018.



Laboratoires URGO launches Ectoin®-containing lozenges

As bitop’s first partner for Ectoin®-containing lozenges, we are proud to announce that Laboratoires URGO launched Ectoin®-containing lozenges in France, Belgium and Poland in the fourth quarter of 2016. The Arabic gum based lozenges are positioned under the HUMER brand of Laboratoires URGO (HUMER MAL DE GORGE AIGU PHARYNGITE) in France and Belgium and are perfectly suited to reduce inflammations and to prevent irritations of the mucous membranes in mouth and throat. Due to the membrane-stabilizing effects of Ectoin®, the lozenges also reduce the danger of a bacterial or viral infection in mouth and throat.
In Poland, the Ectoin® Lozenges are available under the brand name “Ostry Ból Gardła - Laboratoria Polfa Łódź”.



Extension of partnership with company SOLINEA in Poland

In 2016, company SOLINEA introduced two Ectoin® containing medical devices successfully into the Polish market. bitop’s allergy eye drops and inhalation solution are sold under the brand names “ALECTOIN” and “ECTODOSE”. We are proud to announce that SOLINEA has now decided to extend their portfolio with further Ectoin® containing products that will be launched during the next few months.



Turkish company ILKO launches three Ectoin® containing medical devices under the trademark “Wellcare”

Just recently, ILKO launched bitop’s allergy nasal spray, allergy eye drops and mouth and throat spray under the brand names “Ocnarin Nasal Spray”, “Ocnarin Eye Drops” and “Reliflu Mouth and Throat Spray” in Turkey. By adding these products, ILKO extensively broadened it OTC portfolio in the categories Allergy and Cough and Cold.



Mundipharma launches Ectoin® products at the Duphat 2017.

Dubai, 7th – 9th March 2017
At the DUPHAT, the Dubai International Pharmaceuticals and Technologies Conference and Exhibition (DUPHAT), one of the most important annual pharmaceutical events in the Region, Mundipharma has launched the first 4 Ectoin® based products out of the Betadine product range. The products will now be enter the market in the first 12 countries. Subsequently additional countries and products will follow.



Our cosmetic active ingredient Glycoin® natural won the “PCHi Fountain Award 2017”!



Meet us at


in-cosmetics global 2017 in London,
4-6 April

bitop exhibits at the leading event for personal care ingredients and will present latest study data for Ectoin®. Visit us at stand SS72.


Vitafoods Europe 2017 in Geneva,
9-11 May

Get informed about our innovative extremolytes, latest product developments and our whole product range. We are looking forward to discuss about licensing opportunities with you or to simply refresh our contacts. You will find us at booth number Q127 throughout the event.


3rd “Future of Formulations in Cosmetics” Conference in Barcelona,
17-18 May 2017

Attend our speech, held by Eva Galik (Senior Business development) with the topic “Anti-pollution in skin care: fad or real need”?


in-cosmetics Korea in Seoul,
20-22 June 2017

Meet us in Seoul for the third edition of the in-cosmetics in Korea.